论文部分内容阅读
Objective: To study the effects of acetaminophen (ACE) combined with radiation on the progeny of the human glioma cell line SHG-44, and to investigate if ACE may be an useful therapeutic radiosensitivity agent in the treatment of recurrent human glioma. Methods: A randomized, controlled experiment, was performed at the Department of Radiology Laboratory, the First Hospital Affiliated to Soochow University, between September 2004 and January 2006. Brain glioma SHG-44 cells were divided into three groups: SHG-44, SHG-44-10, and SHG-44-10 + ACE cells groups. The SHG-44-10 cells group was irradiated with dose of 10 Gy by a linear accelerator (6 MVX). It was passaged for 15 generations and cultured in RPMI-1640 culture media. Then SHG-44-10 + ACE cells group was treated with ACE. Measures: Community re-double time, mean lethal dose (DO), extrapolation number (N), fraction surviving fraction irradiated by 2 Gy dose (SF2), quasi-threshold dose (Dq), and cell cycle. Results: The SF2 of the SHG-44, SHG-44-10, and SHG44-10 + ACE cells groups were 70.8%, 80.6% and 45.2%, respectively, with significance (P = 0.040). The SHG-44-10 and SHG-44-10 + ACE cells groups were irradiated with 8 Gy. After 12 hours, the G2/M ratio of the SHG-44-10 and SHG-44-10 + ACE cells groups were indicating significantly higher ratio compared to pre-irradiated groups (P